Home
About
Contact
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Business Development

Precision Lifesciences Group

Home
About
Contact
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Business Development
louis-reed-747388-unsplash.jpg

Publications

  • Technology
  • Cancer Immunotherapy
  • Stem-to-T-Cell Platform
  • Dendritic Cell-Based Immunotherapeutics
  • Dendritic Cell-Based Manufacturing
  • Publications
  • Resources
  • A Randomized Double Blind Placebo-Controlled Phase 2 Trial of Dendritic Cell (DC) Vaccine ICT-107 Following Standard Treatment in Newly Diagnosed Patients with GBM
    NEURO-ONCOLOGY, Vol. 16, Issue Suppl. 5, v22, 2014

  • A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Dendritic cell (DC) Vaccination with ICT-107 in Newly Diagnosed Glioblastoma (GBM) Patients.
    2014 ASCO Annual Meeting, Abstract 2005, Citation: J Clin Oncol 32:5s, 2014

  • Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
    CLINICAL AND DEVELOPMENTAL IMMUNOLOGY, Vol. 2012, Article ID 764213

  • Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
    MEDIATORS OF INFLAMMATION, Vol. 2012, Article ID 690643

  • ImmunoCellular Therapeutics ICT-107 Phase 1 results:
    Phase I Trial of a Multi-Epitope-Pulsed Dendritic Cell Vaccine for Patients with Newly Diagnosed Glioblastoma
    CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol. 62, Issue 1, pages 125-135, January 2013

  • The Therapeutic Promise of the Cancer Stem Cell Concept
    THE JOURNAL OF CLINICAL INVESTIGATION, Vol.120, No. 1, pages 41-50, January 2010

  • Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
    STEM CELLS EXPRESS Vol. 27, Issue 8, pages April 23, 2009

  • Isolation of Tumour Stem-like Cells from Benign Tumours
    BRITISH JOURNAL OF CANCER Vol. 101, No. 2, pages 303 – 311, 2009

  • Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
    CANCER RESEARCH, Vol. 68, No.14, pages 5955-5964, July 15, 2008

  • Cancer Vaccines: A Novel Strategy to Sensitize Malignant Glioma to Chemotherapy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, Vol. 7 No. 10, pages 1235–1237, 2007

  • Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma
    CANCER RESEARCH, Vol. 64, pages 4973– 4979, July 15, 2004

  • HER-2, gp100, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells
    THE NEW YORK TIMES, by Nicholas Wade, Page A1, August 13, 2009

  • Vaccination of Malignant Glioma Patients with Peptide-pulsed Dendritic Cells,
    CANCER RESEARCH, Vol. 61, pages 842– 847, February 1, 2001

Newsletter Block
This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

Subscribe

Sign up with your email address to receive news and updates.

Thank you!
Back to Top

Terms of Use | Privacy Policy